Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Techdow Pharma Netherlands BV

Home Clinical Trial Sponsors and OrganizationsTechdow Pharma Netherlands BV

Techdow Pharma Netherlands BV

ACTIVE

NetherlandsSubsidiary

Part of 深圳市海普瑞药业集团股份有限公司

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

0

0 active

Approvals

9

Total approvals

Agencies

2

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

No trial data available

Clinical Trials

No trial data available

Approvals

Approvals by Agency

EMA

European Medicines Agency

2

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

7

Approvals

Recent Approvals

INHIXA 12.000 UI (120 MG)/0,8 ML SOLUCION INYECTABLE

INHIXA 15.000 UI (150 MG)/1 ML SOLUCION INYECTABLE

INHIXA 10.000 UI (100 MG)/1 ML SOLUCION INYECTABLE

INHIXA 8.000 UI (80 MG)/0,8 ML SOLUCION INYECTABLE

INHIXA 2.000 UI (20 MG)/0,2 ML SOLUCION INYECTABLE

INHIXA 6.000 UI (60 MG)/0,6 ML SOLUCION INYECTABLE

INHIXA 4.000 UI (40 MG)/0,4 ML SOLUCION INYECTABLE

News

No news articles found

On this page

Overview
Clinical Trials
Approvals9
News

Back to Organizations